2019
Medication Appropriateness in Vulnerable Older Adults: Healthy Skepticism of Appropriate Polypharmacy
Fried TR, Mecca MC. Medication Appropriateness in Vulnerable Older Adults: Healthy Skepticism of Appropriate Polypharmacy. Journal Of The American Geriatrics Society 2019, 67: 1123-1127. PMID: 30697698, PMCID: PMC6561813, DOI: 10.1111/jgs.15798.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overChronic DiseaseDrug PrescriptionsDrug-Related Side Effects and Adverse ReactionsFemaleHumansInappropriate PrescribingMalePolypharmacyConceptsNumber of medicationsAppropriate polypharmacyOlder adultsMedication benefitsComplex medication regimensMultiple chronic conditionsVulnerable older adultsMedication appropriatenessUnderestimate harmsInappropriate medicationsMore medicationsAdverse eventsMore observational studiesMedication regimensComplex regimenAdverse outcomesAppropriate medicationChronic conditionsMedications resultsObservational studyPolypharmacyMedicationsHealth outcomesCorrect medicationLikelihood of harm
2011
Effects of Benefits and Harms on Older Persons' Willingness to Take Medication for Primary Cardiovascular Prevention
Fried TR, Tinetti ME, Towle V, O’Leary J, Iannone L. Effects of Benefits and Harms on Older Persons' Willingness to Take Medication for Primary Cardiovascular Prevention. JAMA Internal Medicine 2011, 171: 923-928. PMID: 21357797, PMCID: PMC3101287, DOI: 10.1001/archinternmed.2011.32.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAspirinCardiotonic AgentsCardiovascular DiseasesDrug-Related Side Effects and Adverse ReactionsFemaleHealth Knowledge, Attitudes, PracticeHumansInterviews as TopicMaleMyocardial InfarctionPatient CompliancePatient ParticipationPatient SelectionPharmaceutical PreparationsPrimary PreventionRisk AssessmentSurveys and QuestionnairesConceptsPrimary cardiovascular disease preventionCardiovascular disease preventionMyocardial infarctionAbsolute benefitAdverse effectsDisease preventionOlder personsCommunity-living older personsPrimary cardiovascular preventionEvidence-based guidelinesAverage risk reductionRisk reductionCardiovascular preventionAvailable medicationsPrimary preventionClinical guidelinesTreatment benefitMild fatigueMedicationsQuality assurance initiativesPerson interviewsPreventionParticipantsHarmLarge proportion
2010
Electronic health records and adverse drug events after patient transfer
Boockvar K, Livote E, Goldstein N, Nebeker J, Siu A, Fried T. Electronic health records and adverse drug events after patient transfer. BMJ Quality & Safety 2010, 19: e16. PMID: 20724395, PMCID: PMC2965207, DOI: 10.1136/qshc.2009.033050.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overCohort StudiesConnecticutDrug-Related Side Effects and Adverse ReactionsElectronic Health RecordsFemaleHospitalsHumansMaleMedical AuditMiddle AgedNew YorkNursing HomesPatient TransferConceptsAdverse drug eventsHigh-risk medication discrepanciesElectronic health recordsMedication discrepanciesSite of careDrug eventsPatient transferStructured medical record reviewNon-VA groupsNon-VA patientsVeterans Affairs patientsHealth recordsMedical record reviewGroup of patientsPairs of physiciansHospitalisation episodesMedication reviewHospital transferOverall incidenceRecord reviewClinical covariatesMedication errorsNursing homesPatientsTime of transfer